RCP
Rho Capital Partners Portfolio holdings
AUM
$20.4M
This Quarter Return
+85.71%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$154M
AUM Growth
+$55.1M
(+56%)
Cap. Flow
-$6.74M
Cap. Flow
% of AUM
-4.36%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
+$6.74M |
Sector Composition
| 1 | Healthcare | 91.23% |
| 2 | Communication Services | 8.73% |
| 3 | Technology | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $74.4M | 48.16% |
3,766,666
| – | – |
|
|
TVRD
2
Tvardi Therapeutics, Inc. Common Stock
TVRD
$332M
| $47.9M | 31% |
77,752
-10,944
| -12% | -$6.74M |
|
3
Mersana Therapeutics
MRSN
$37.3M
| $18.6M | 12.07% |
31,858
| – | – |
|
4
LiveOne
LVO
$61.4M
| $13.5M | 8.73% |
3,724,138
| – | – |
|
5
Senseonics Holdings
SENS
$371M
| $62K | 0.04% |
159,601
| – | – |
|